A.M. Bove
University of Southern California
11 Papers
24 Citations
A.M. Bove is an academic researcher from University of Southern California. The author has contributed to research in topics: Nephrectomy & Robotic surgery. The author has an hindex of 3, co-authored 11 publications.
Chat about Author
Papers
Robot-assisted Level II–III Inferior Vena Cava Tumor Thrombectomy: Step-by-Step Technique and 1-Year Outcomes
Sameer Chopra,Giuseppe Simone,Charles Metcalfe,Andre Luis de Castro Abreu,Jamal Nabhani,Mariaconsiglia Ferriero,A.M. Bove,Rene Sotelo,Monish Aron,Mihir M. Desai,Michele Gallucci,Inderbir S. Gill +11 more
TL;DR: Robotic IVC tumor thrombectomy is feasible for level II-III thrombi and even patients with advanced kidney cancer could now benefit from robotic surgery with a quicker recovery.
124
Outcomes of robot-assisted partial nephrectomy for completely endophytic renal tumors: A multicenter analysis.
Umberto Carbonara,Giuseppe Simone,Andrea Minervini,Chandru P. Sundaram,Alessandro Larcher,Jennifer J. Lee,Enrico Checcucci,Cristian Fiori,Devin Patel,Margaret Meagher,Fabio Crocerossa,Alessandro Veccia,Lance J. Hampton,Pasquale Ditonno,Michele Battaglia,Aldo Brassetti,A.M. Bove,Andrea Mari,Riccardo Campi,Marco Carini,Jay Sulek,Francesco Montorsi,Umberto Capitanio,Daniel Eun,Francesco Porpiglia,Ithaar Derweesh,Riccardo Autorino +26 more
TL;DR: The findings confirm that RAPN in case of completely endophytic renal masses can be performed with acceptable outcomes in centers with significant robotic expertise and that clinical tumor size was only significant predictor for trifecta achievement.
43
Robot-assisted partial nephrectomy: 7-year outcomes.
Umberto Carbonara,Giuseppe Simone,Umberto Capitanio,Andrea Minervini,Cristian Fiori,Alessandro Larcher,Enrico Checcucci,Daniele Amparore,Fabio Crocerossa,Alessandro Veccia,Samuel Weprin,Pasquale Ditonno,Aldo Brassetti,A.M. Bove,Andrea Mari,Antonio Andrea Grosso,Marco Carini,Francesco Montorsi,Lance J. Hampton,Michele Gallucci,Francesco Porpiglia,Riccardo Autorino +21 more
TL;DR: The findings show excellent 7-year oncologic and functional outcomes of patients who underwent RAPN for a malignant mass with a median follow-up of 7-yr, the longest following-up to date.
31
Primary Whole-gland Cryoablation for Prostate Cancer: Biochemical Failure and Clinical Recurrence at 5.6 Years of Follow-up.
Masakatsu Oishi,Masakatsu Oishi,Inderbir S. Gill,Akbar Ashrafi,Michael Lin-Brande,Nima Nassiri,Toshitaka Shin,A.M. Bove,Giovanni Cacciamani,Osamu Ukimura,Duke Bahn,Duke Bahn,Andre Luis de Castro Abreu +12 more
TL;DR: Cryoablation is a safe, minimally-invasive procedure that uses cold temperatures delivered via probes through the skin to kill prostate cancer (PCa) cells and those with a prostate-specific antigen value ≥0.2ng/ml within 6 mo after treatment were more likely to have PCa recurrence.
22
Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study
Manuela Spagnuolo,Manuela Costantini,Mariaconsiglia Ferriero,Marco Varmi,Isabella Sperduti,Giulia Regazzo,Lucia Cicchillitti,Ana Belén Díaz Méndez,Giovanni Cigliana,Vincenzo Pompeo,Andrea M. Russo,Valentina Laquintana,Riccardo Mastroianni,Giulia Piaggio,Umberto Anceschi,Aldo Brassetti,A.M. Bove,Gabriele Tuderti,Rocco Simone Flammia,Michele Gallucci,Giuseppe Simone,Maria Giulia Rizzo +21 more
TL;DR: Urinary let-7c cluster evaluation may improve prognosis, identifying patients at risk of progression and addressing early radical treatment, and a benefit was evident for patients with a PFS probability > 20%.
19